EQT, Goldman to buy clinical research firm Parexel for $8.5 bln

  • 7/2/2021
  • 00:00
  • 5
  • 0
  • 0
news-picture

July 2 (Reuters) - Swedish private equity firm EQT AB and Goldman Asset Management said on Friday they will buy clinical research company Parexel International Corp from Pamplona Capital Management for $8.5 billion. Reporting by Sohini Podder in Bengaluru; Editing by Krishna Chandra Eluri Our Standards: The Thomson Reuters Trust Principles.

مشاركة :